The hypoglycemic mechanism of liraglutide relies on it can increase insulin secretion and alpha beta-cell action to inhibit glucagon release, which leads to decreased plasma glucose in diabetes patients, and the role of central nervous receptors to increase satiety delayed gastric emptying [39]. Here, INS is linked to diabetes mellitus.